PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was TWD 2,152.48 million compared to TWD 1,229.47 million a year ago. Net loss was TWD 938.3 million compared to TWD 815.56 million a year ago. Basic loss per share from continuing operations was TWD 2.98 compared to TWD 2.93 a year ago.